Navigation Links
SOCMA Announces Launch of SCD-iBIO Group

WASHINGTON, April 25, 2012 /PRNewswire-USNewswire/ -- The Society of Chemical Manufacturers and Affiliates (SOCMA) today announced the launch of SCD-iBIO, a new affiliate group that aims to advance the commercialization of industrial biotechnology, which is the application of biology for the production and processing of chemicals, pharmaceuticals, materials and energy.

The group is referred to by its acronym, which stands for the Society for the Commercial Development of Industry Biotechnology.

"With industrial biotechnology rapidly emerging as a key technology for economic growth on a global scale, SCD-iBIO will help member companies achieve their common objective of creating a sustainable chemical industry," said SOCMA President and CEO Lawrence D. Sloan. "We welcome them into our family of affiliate groups and look forward to helping them achieve their goals."

Sloan added that the formation of the group also supports SOCMA's organizational goal to expand its representation across more sectors of the chemical space.

"We feel that industrial biotechnology is at an inflection point, and the practice of commercial development would accelerate the penetration of the field," said Larry Drumm, Executive Director of SCD-iBIO.

Members of SCD-iBIO are dedicated to developing and commercializing products that are:

  • Derived from renewable feedstocks;
  • Manufactured by green process technology;
  • Produced with lower life-cycle carbon emissions using bioprocesses;
  • Or companies that are part of the value chain.

Through SCD-iBIO, member companies can participate in forums to share best practices, have access to educational opportunities and take part in networking functions.

SOCMA's Association Management Services offers professional and administrative services to manage independent chemical and related industry associations. A variety of single-chemical, issue-specific or industry sector groups have operated as separately funded, affiliated associations under SOCMA management since the early 1970s.

SOCMA is the only U.S.-based trade association dedicated solely to the batch, custom and specialty chemical industry. Since 1921, we have represented a diverse membership of small, medium and large chemical companies, making us the leading authority on this sector. SOCMA has a global membership of 220 companies, which employ more than 46,000 workers in the U.S. alone.

Available Topic Expert: For information on the listed expert, click appropriate link.
Lawrence D. Sloan --

Christine Sanchez
Sr. Manager, Public Relations & Media
(202) 721-4182


SOURCE Society of Chemical Manufacturers and Affiliates
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. SOCMA President to Lead ChemOutsourcing Keynote Panel on API Supply Base on Wednesday, September 15 at New Jersey Show
2. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
3. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
4. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
5. Anesiva Announces Second Quarter 2008 Financial Results and Update
6. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
7. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
8. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
9. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
10. ThirdBiotech Announces Kemeta as Newest Sponsor
11. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... CA (PRWEB) , ... June 23, 2016 , ... ... software, is exhibiting at the Pennsylvania Convention Center and will showcase its product’s ... conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials ...
(Date:6/23/2016)... June 23, 2016 ... report to its pharmaceuticals section with historic and ... and much more. Complete report on ... pages, profiling 15 companies and supported with 261 ... . The Global Cell ...
Breaking Biology Technology:
(Date:6/22/2016)... , June 22, 2016 On Monday, the ... to industry to share solutions for the Biometric Exit ... Customs and Border Protection (CBP), explains that CBP intends ... departing the United States , in ... to defeat imposters. Logo - ...
(Date:6/9/2016)... 9, 2016  Perkotek an innovation leader in attendance control systems is proud to ... hours, for employers to make sure the right employees are actually signing in, and ... ... ... ...
(Date:6/2/2016)...   The Weather Company , an IBM Business (NYSE: ... capability in which consumers will be able to interact with ... via voice or text and receive relevant information about the ... Marketers have long sought an advertising solution that can create ... relevant and valuable; and can scale across millions of interactions ...
Breaking Biology News(10 mins):